My7's E Cigarettes Introduce Grape Cartomizers to Their Lineup

A favorite in e liquid is now added to pre filled cartomizers for the entire My7's e cigarette line because of demand for the popularity of the flavor.

2012-07-24

COLLEYVILLE, TX, July 24, 2012 (Press-News.org) From zero nicotine to high, My7's grape flavor has been a huge hit among users of the popular brand. Now the company releases its pre-filled cartomizers for the public.

The company has been aggressively adding a plethora of flavors to meet the demand of smokers across the country and is expected to explode sales of the already popular brand.

Flavors offer smokers more options when it comes to the new smoking alternative that is taking the nation and world by storm. While there are some naysayers, most agree that flavors add a new and refreshing change for smokers by adding options that never were available with such vibrant flavors.

"The demand for our Grape e liquid was phenomenal and we had a lot of request for pre-filled cartomizers with that flavor for the vapers on the go, so we answered the call." States Kyle Newton, President of My7's.com. "Our new cartomizers are bursting with flavors that is vibrant and clean and no lingering and dull after taste like other producers. We're also giving away a free charging case to anyone who buys a 40 pack of cartomizers through a coupon code that can be found on our blog."

The company offers the most extensive line of e cigarette kits on the market today and has a leading research and development team that continues to come up with better engineered and intuitive products that sets the standards of the electronic cigarette industry.

My7's is a top e cigarette retailer in the United States and is dedicated to customer satisfaction and quality products. Visit their website at http://www.my7s.com/.

ELSE PRESS RELEASES FROM THIS DATE:

deVere Group Announces Strong Half-Year Results

2012-07-24

After announcing massive expansion plans across all 5 continents last year, with the number of offices now totalling 69, of which 13 branches were opened in this year alone, deVere CEO Nigel Green is delighted to announce that the efforts have paid off with very successful results. As of June 2012, year-to-date figures have increased by 15% from 2011. Notably, its new currency service deVere Foreign Exchange is growing rapidly, by a staggering 434% since last year. The deVere Fund Platform, the industry-leading interactive hub which holds a 5,000+ fund selection, is ...

For gay couples, condom decision-making and condom use varies by race

2012-07-23

Black gay couples tend to practice safe sex but don't talk about it, while white gay couples discuss safety but are less likely to use condoms, according to new findings presented at the 19th International AIDS Conference. Gay men, particularly white and black men, account for the majority of new HIV cases in the United States. One source of HIV infection could be men's primary relationship partners. To explore this aspect of risk, San Francisco State University researchers studied how black, white and interracial male couples make decisions about using condoms. In ...

Clinical study in rural Uganda shows high demand for antiretroviral drugs

2012-07-23

An ongoing clinical study in rural Uganda, begun in 2011, suggests that many people infected with HIV/AIDS would take antiretroviral drugs if they were available to them—even before they developed symptoms from the disease. Led by doctors at the University of California, San Francisco (UCSF), the San Francisco General Hospital and Trauma Center (SFGH) and Makerere University School of Medicine in Kampala, Uganda, the study is the first to address such attitudes among African patients who are in the early stages of the disease and not yet sick. Historically, treatment ...

Increased cardiovascular risk in HIV-infected patients may relate to arterial inflammation

2012-07-23

The elevated risk of cardiovascular disease seen in patients infected with HIV appears to be associated with increased inflammation within the arteries, according to a study that will appear in a special issue of JAMA published in conjunction with the International AIDS Conference. The report from Massachusetts General Hospital (MGH) found that levels of inflammation within the aortas of HIV-infected individuals with neither known cardiovascular disease nor elevated traditional risk factors were comparable to those of patients with established cardiovascular disease. "Several ...

HIV suppression not as good as previously thought, largest study of viral-load blood tests show

2012-07-23

Tens of thousands of Americans taking potent antiretroviral therapies, or ART, to keep their HIV disease in check may not have as much control over the viral infection as previous estimates have suggested, according to results of a study by AIDS experts at Johns Hopkins and the University of Pennsylvania. In what is believed to be the largest and longest review of viral load test results in people with HIV disease ever performed in the United States, researchers found that the number of people sustaining viral suppression – consistently, at 400 or less viral copies ...

HIV-infected women do not appear to be at increased risk of cervical cancer

2012-07-23

WASHINGTON, D.C. – HIV-infected and uninfected women with normal cervical cytology (Pap test) and a negative test result for oncogenic (tumor inducing) human papillomavirus DNA at study enrollment had a similar risk of cervical precancer and cancer after 5 years of follow-up, according to a study in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Howard D. Strickler, M.D., M.P.H., of the Albert Einstein College of Medicine of Yeshiva University, New York, presented the findings of the study at a JAMA media briefing at the International AIDS Conference. "U.S. ...

Working toward an AIDS-free generation

2012-07-23

WASHINGTON, D.C. – Ending the global HIV/AIDS pandemic may be possible by implementing a multifaceted global effort that expands testing, treatment, and prevention programs, as well as meets the scientific challenges of developing an HIV vaccine and possibly a cure, according to a Viewpoint in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Md., presented the article at a JAMA media briefing at the International AIDS Conference. Dr. Fauci and co-author ...

Benefits of HIV drugs rise -- but less than previously believed, Penn study shows

2012-07-23

PHILADELPHIA – The percentage of HIV patients taking antiretroviral drugs who experienced the full benefit of the drugs jumped from 45 percent of 72 percent during the past decade, a figure that is lower than previous estimates. The findings, considered important for HIV prevention efforts, since patients whose virus is in tight control are less likely to transmit the infection to others, are published this week in JAMA by a team of researchers led by the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins University School of Medicine. The issue's ...

Study examines characteristics, risk factors among HIV-positive persons born outside the US

2012-07-23

WASHINGTON, D.C. – An examination of the characteristics of persons born outside the United States diagnosed with HIV while living in the U.S. finds that, compared to U.S.-born persons with HIV, they are more likely to be Hispanic or Asian, and to have a higher percentage of HIV infections attributed to heterosexual contact, according to a study appearing in JAMA being published online. H. Irene Hall, Ph.D., of the Centers for Disease Control and Prevention, Atlanta, presented the findings of the study at a JAMA media briefing at the International AIDS Conference. "Persons ...

Artificial jellyfish swims in a heartbeat

2012-07-23

Cambridge, Mass. — July 22, 2012 — Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish." The finding serves as a proof of concept for reverse engineering a variety of muscular organs and simple life forms. It also suggests a broader definition of what counts as synthetic life in an emerging field that has primarily focused on replicating life's ...